HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diclazuril, a new broad spectrum anticoccidial drug in chickens. 1. Dose titration studies and pilot floor pen trials.

Abstract
Diclazuril, a new anticoccidial drug, was tested in poultry against six Eimeria species either in single species infections in dose titration studies or in mixed species infections in floor pen trials. The dose titration studies in cockerels indicated that diclazuril at dosages of 10, 5, 1, and .5 ppm was highly active against all major pathogenic species: E. tenella, E. acervulina, E. necatrix, E. brunetti, E. maxima, and E. mitis and effective in terms of weight gain and suppression of mortality, dropping scores, and oocyst counts. In two floor pen trials diclazuril was fed for 6 wk to broiler chickens experimentally infected either with E. tenella and E. acervulina or with E. necatrix and E. brunetti. Dose levels of 10, 5, and 1 ppm suppressed mortality and lesion scores. Even at 1 ppm the mean terminal body weight, feed conversion, and productivity index of treated birds were comparable to results for the uninfected, unmediated controls. In these pilot studies, involving 1,020 Hisex and 1,000 Hubbard broiler chickens, it has been demonstrated that diclazuril at the dose level of 1 ppm in the diet is an excellent anticoccidial without any adverse effects.
AuthorsO Vanparijs, R Marsboom, L Desplenter
JournalPoultry science (Poult Sci) Vol. 68 Issue 4 Pg. 489-95 (Apr 1989) ISSN: 0032-5791 [Print] England
PMID2748496 (Publication Type: Journal Article)
Chemical References
  • Coccidiostats
  • Nitriles
  • Triazines
  • diclazuril
Topics
  • Animals
  • Chickens
  • Coccidiosis (drug therapy, veterinary)
  • Coccidiostats (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Eimeria (drug effects)
  • Male
  • Nitriles (pharmacology, therapeutic use)
  • Poultry Diseases (drug therapy)
  • Triazines (pharmacology, therapeutic use)
  • Weight Gain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: